The MED23 gene helps your cells switch many other genes on at the right time, especially during brain development. If it does not work properly, it can lead to a genetic condition marked by developmental delay, intellectual disability, major speech difficulties, and sometimes low muscle tone or seizures. MED23 is part of a larger cell control system that helps the body respond to signals and make proteins when they are needed.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or direct processes in the body. Some genes give the directions for producing proteins, the parts of cells that do the work. Others mainly regulate when specific processes happen, where they happen, and how strongly they are carried out. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this topic in more detail, you can find more in the LearnHub.
Overview
MED23Gene function
What if the gene works
The MED23 gene helps control when other genes are switched on. Its protein is part of a larger cell complex that passes signals needed for normal growth, development, and brain function.
Risk
What if the gene does not work
Variants in the MED23 gene can cause developmental delay, especially affecting speech and learning, sometimes with low muscle tone. Some people also have seizures or a small head size. Milder or more severe variants can shape timing and severity.
Treatment
What does that mean for your treatment
No MED23-specific treatment or management approach is currently established for people with pathogenic variants in the MED23 gene. Care is supportive and based on a person’s symptoms, while MED23 is still mainly being studied in early research, including cancer biology.
Conditions associated with MED23
Gene function
What if the gene works
Your cells are always deciding which instructions to use. The MED23 gene helps manage that process by supporting gene activity at the right time. It is part of a larger helper group that links control signals to the cell machinery that starts making RNA, a working copy of a gene. That helps explain what the MED23 gene does in the body every day.
The MED23 gene is part of the mediator complex, a protein team that passes messages from gene control proteins to the machinery that reads DNA. This helps cells turn selected genes on in a controlled way.
One of its main jobs is to help RNA polymerase II, the enzyme that makes RNA copies of genes, begin its work. This supports the first step in using genetic instructions.
Your cells receive many routine signals that tell them when to grow, communicate, or adjust activity. MED23 helps turn some of these signals into changes in gene activity.
By helping the right genes switch on at the right time, MED23 supports normal cell growth and cell specialization. This lets different tissues follow their own instruction sets while sharing the same DNA.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change a gene’s function more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
When the MED23 gene carries a variant, the protein may be shortened, unstable, or less able to join the larger protein group that controls gene activity. Descriptions of what happens if the MED23 gene does not work properly include a spectrum from milder variants that leave some activity to more severe variants that sharply reduce or remove it. Lower remaining activity can disrupt cell signaling more and, in MED23-related developmental conditions, may be linked to earlier or more noticeable features.
How variants are linked to conditions
Pathogenic variants in the MED23 gene can cause a rare inherited neurodevelopmental condition marked by developmental delay, intellectual disability, and often major speech delay. Some people also have seizures, muscle stiffness, or a smaller than expected head size. This MED23 gene developmental delay and intellectual disability pattern is most often seen when both copies of the gene carry a disease causing variant.
A variant is not necessarily a diagnosis
Gene variants are a usual part of human biology and are widely seen in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors both play a role. In some situations, though, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks related to the MED23 gene. In families with a disease-causing change in both copies of MED23, risk is mainly shaped by inheritance rather than lifestyle, and a doctor or genetic counselor can help explain personal and family risk.
Inheritance of MED23 variants
MED23-related conditions are usually inherited in an autosomal recessive pattern. In practical terms, MED23 gene inheritance most often means a child inherits one altered copy of the MED23 gene from each parent; parents who carry one variant usually do not have the condition themselves. When both parents are carriers, each pregnancy has a 25% chance of the child inheriting both altered copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither altered copy. This pattern affects boys and girls equally.
What does my MED23 result mean for my family?
For MED23, the best-known family pattern is recessive. This usually means parents are healthy carriers, and brothers or sisters may also be carriers or, less often, have the condition. Close relatives may want to learn whether the same MED23 change is present in the family, especially when there is a history of developmental delay or learning problems.
Genetic information
Genetic testing
How you find out about variants
Variants in the MED23 gene are found through genetic testing, usually using a blood or saliva sample to read the gene's DNA code. MED23 genetic testing may be included in a multigene panel or broader sequencing, and results can show whether a variant is present and whether it may explain symptoms.
When should I consider getting a genetic test?
Genetic testing for the MED23 gene may be considered when a child has unexplained developmental delay, learning problems, or very limited speech, especially if similar problems run in the family. It can also help when a MED23 change has already been found in a relative.
A genetic result is only one part of your health story
Genetic results can provide valuable insight, but how much they reveal varies based on the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, also influence how the body functions over time. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best considered together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may also help make sense of an individual’s experience.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small inherited differences can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. That helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. It studies the relationship between genes and drugs to better explain why the same treatment may work differently from one person to another. For many medicines, genes can affect both how strongly a drug works and how the body handles it. This understanding can support more informed and more individualized treatment decisions. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the MED23 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines. If you have concerns about side effects, a new prescription, or whether your health condition could affect treatment, talk with your doctor or pharmacist.
History
MED23 entered the scientific literature as researchers worked to map the human Mediator complex, a major milestone in understanding how genes are regulated. First described in the scientific literature as part of early genetics, it was initially known through broader studies of transcription, the process cells use to read genetic instructions. Over time, descriptions became more precise as scientists matched individual Mediator components to specific genes and renamed them in a more systematic way. Interest in MED23 grew further when inherited MED23 variants were linked to developmental and neurologic conditions in affected families. These historical steps shaped today’s understanding of MED23 as one member of a much larger gene control system.